Evidence map›Paper›PMID 35041207›Full record

ArticleMedical physics2022

Beam properties within the momentum acceptance of a clinical gantry beamline for proton therapy.

Anna Chiara Giovannelli, Vivek Maradia, David Meer, Sairos Safai, Serena Psoroulas, Michele Togno, Christian Bula, Damien Charles Weber, Antony John Lomax, Giovanni Fattori

Abstract read
In one paragraph

Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna Chiara GiovannelliCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Vivek MaradiaCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
David MeerCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Sairos SafaiCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Serena PsoroulasCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Michele TognoCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Christian BulaCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Damien Charles WeberCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Antony John LomaxCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.
Giovanni FattoriCenter for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland.

Funding

Swiss National Science Foundation 185082
6 · The paper itself

Abstract

purposeEnergy changes in pencil beam scanning proton therapy can be a limiting factor in delivery time, hence, limiting patient throughput and the effectiveness of motion mitigation techniques requiring fast irradiation. In this study, we investigate the feasibility of performing fast and continuous energy modulation within the momentum acceptance of a clinical beamline for proton therapy.

methodsThe alternative use of a local beam degrader at the gantry coupling point has been compared with a more common upstream regulation. Focusing on clinically relevant parameters, a complete beam properties characterization has been carried out. In particular, the acquired empirical data allowed to model and parametrize the errors in range and beam current to deliver clinical treatment plans.

resultsFor both options, the local and upstream degrader, depth-dose curves measured in water for off-momentum beams were only marginally distorted (γ(1%, 1 mm) > 90%) and the errors in the spot position were within the clinical tolerance, even though increasing at the boundaries of the investigated scan range. The impact on the beam size was limited for the upstream degrader, while dedicated strategies could be required to tackle the beam broadening through the local degrader. Range correction models were investigated for the upstream regulation. The impaired beam transport required a dedicated strategy for fine range control and compensation of beam intensity losses. Our current parameterization based on empirical data allowed energy modulation within acceptance with range errors (median 0.05 mm) and transmission (median -14%) compatible with clinical operation and remarkably low average 27 ms dead time for small energy changes. The technique, tested for the delivery of a skull glioma treatment, resulted in high gamma pass rates at 1%, 1 mm compared to conventional deliveries in experimental measurements with about 45% reduction of the energy switching time when regulation could be performed within acceptance.

conclusionsFast energy modulation within beamline acceptance has potential for clinical applications and, when realized with an upstream degrader, does not require modification in the beamline hardware, therefore, being potentially applicable in any running facility. Centers with slow energy switching time can particularly profit from such a technique for reducing dead time during treatment delivery.

Indexed as

Proton TherapyHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedSynchrotronsWaterWatergantrymomentum acceptancepencil beam scanningproton therapytreatment delivery

Identifiers

PMID35041207
PMCPMC10234452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.